Chiang I H, Yu M C, Bai K J, Wu M P, Hsu C J, Lin T P, Luh K T
Taiwan Provincial Chronic Disease Control Bureau, Taipei, Taiwan.
J Formos Med Assoc. 1998 Aug;97(8):581-3.
To evaluate the patterns of drug resistance of Mycobacterium tuberculosis in Taiwan, a total of 1,091 isolates collected from patients from January 1996 through December 1996 were tested for drug susceptibility using the absolute concentration method at the Taiwan Provincial Chronic Disease Control Bureau. The overall drug rate of resistance to at least one drug was 35.5%. Among the 249 isolates from patients who had never been treated for tuberculosis, 16.1% were resistant to one or more drugs; 1.6% were resistant to at least isoniazid and rifampin. Of 200 patients with prior antituberculosis treatment, 67.0% had isolates resistant to one or more drugs and 46.0% had isolates resistant to at least isoniazid and rifampin. We conclude that drug-resistant M. tuberculosis is an important issue in tuberculosis treatment in Taiwan, especially when dealing with patients with a prior history of antituberculosis treatment. More aggressive interventions, such as directly observed therapy, short-course, are needed to improve the cure rate of pulmonary tuberculosis and to decrease resistance rates.
为评估台湾地区结核分枝杆菌的耐药模式,1996年1月至12月期间从台湾地区慢性病防治局的患者中收集了1091株分离菌,采用绝对浓度法进行药敏试验。对至少一种药物的总体耐药率为35.5%。在249例从未接受过抗结核治疗的患者的分离菌中,16.1%对一种或多种药物耐药;1.6%对至少异烟肼和利福平耐药。在200例既往接受过抗结核治疗的患者中,67.0%的分离菌对一种或多种药物耐药,46.0%的分离菌对至少异烟肼和利福平耐药。我们得出结论,耐药结核分枝杆菌是台湾地区结核病治疗中的一个重要问题,尤其是在治疗有抗结核治疗史的患者时。需要采取更积极的干预措施,如直接观察治疗、短程治疗,以提高肺结核的治愈率并降低耐药率。